Atropine
Active ingredient · 2 therapeutic classes
- Drug class
- Belladonna Alkaloids, Tertiary Amines
- Availability
- Prescription only
- Routes
- Intramuscular, Intravenous, Ophthalmic, Endotracheal, Intramedullary
- Markets covered
- 3
- Products on record
- 33
Overview
Plain-language summary, compiled from the cited regulatory records
Atropine is a medication belonging to the Belladonna Alkaloids and Tertiary Amines drug class [1]. It is approved for the temporary blockade of severe or life-threatening muscarinic effects [1]. Specifically, atropine is indicated for use as an antisialagogue (to reduce saliva and other secretions), an antivagal agent (to counteract the effects of the vagus nerve), and as an antidote for poisoning by organophosphorus compounds or muscarinic mushrooms [1]. Additionally, it is used in the treatment of bradyasystolic cardiac arrest [1].
Atropine is available in the market under various brand names [1]. (Note: The provided data did not list specific brand examples to include here).
This medication is administered via injection [1]. (Note: The provided data did not include adverse event report counts to mention here).
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 19 | May 1, 2026 |
| CA Canada | Health Canada | 8 | July 9, 2025 |
| US United States | FDA | 6 | March 10, 2026 |
GBUnited Kingdom· MHRA
19 products
Uses
Atropine sulfate is an antimuscarinic agent used as a cycloplegic and mydriatic. The eye drops are used in the treatment of iritis and uveitis to immobilise the iris and ciliary muscle and to prevent or break down adhesions. Since it is a powerful cycloplegic it is used in the determination of refraction in children below six years and children with convergent strabismus.
How to take
CACanada· Health Canada
8 products
Uses
AND CLINICAL USE .................................................................................................................. 4 CONTRAINDICATIONS ...................................................................................................................................
4 WARNINGS .................................................................................................................................................... 5 PRECAUTIONS ...............................................................................................................................................
5 ADVERSE REACTIONS .................................................................................................................................... 6 OVERDOSAGE ................................................................................................................................................
6 DOSAGE AND ADMINISTRATION .................................................................................................................. 7 DOSAGE FORM, COMPOSITION, AND PACKAGING ......................................................................................
USUnited States· FDA
6 products
Uses
1. 3 Penalization of the Healthy Eye in the Treatment of Amblyopia
How to take
Drug interactions
Known interactions involving Atropine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 357. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL311030027 · revised May 1, 2026
- [2]Health Canada (DPD) · 02426269 · revised July 9, 2025
- [3]FDA DailyMed · 127a7e32-a150-01… · revised March 10, 2026 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.